Abstract:Emissions of complex mixtures of polycyclic aromatic hydrocarbons (PAHs) and other compounds into the environment represent a potential threat to the health of humans. Information regarding the dose and duration of exposure is essential to determine the degree of risk and to identify sensitive receptors within a population. Although measurements of chemical concentrations in air may be used to estimate exposures, internal biomarkers provide more accurate information regarding the dose of exposure and retention of toxic chemicals. This study was conducted in a population in rural China exposed to PAHs from a variety of sources. The study population was located in an area known to have an elevated incidence of birth defects. Parents of children born with a neural tube defect (NTD) were recruited as case participants and parents of children born with no visible birth defect were recruited as controls. The study was designed to test the hypothesis that parents of children born with a NTD would exhibit a biomarker of exposure at higher levels than the parents of a child with no visible birth defect. A total of 35 mothers and 32 fathers were recruited as case participants, and 18 mothers and 19 fathers were recruited as control participants. Venous blood was collected from the study participants by hospital staff as soon as possible following the birth of the child. PAHs were isolated from the whole blood by solvent extraction and DNA was isolated from a separate aliquot of blood for 32P-postlabeling to measure bulky adducts. Single Nucleotide Polymorphisms (SNPs) in phase II enzymes were also monitored in an attempt to identify sensitive receptors. Both total and carcinogenic PAH (cPAH) concentrations were elevated in the parents of case children. Both values were elevated significantly in mothers, whereas only cPAH concentrations were elevated significantly in fathers. Levels of DNA adducts were highly variable and displayed a reverse pattern to that of PAH levels in blood. None of the polymorphisms evaluated were correlated with PAH levels or DNA adducts. For mothers, whose total PAH concentration was above the median concentration, the age-adjusted odds ratio (OR) for having a child with a NTD was 8.7. Although this suggests that PAHs may be a contributing factor to the risk of NTDs, the lack of a correlation with DNA adducts would suggest a possible non-genotoxic mechanism. Alternatively, the PAHs may be a surrogate for a different exposure that is more directly related to the birth defects. The results have shown that blood levels of PAHs may be used to identify populations exposed to elevated concentrations of combustion by-products.

Periconceptional polycyclic aromatic hydrocarbon levels in maternal hair and fetal risk for congenital heart defects

Assessment of interaction between maternal polycyclic aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart diseases

Exposure to Polycyclic Aromatic Hydrocarbons and Risk for Premature Ovarian Failure and Reproductive Hormones Imbalance

Prenatal exposure to poly/perfluoroalkyl substances and risk for congenital heart disease in offspring

Co-exposure to phthalates and polycyclic aromatic hydrocarbons and the risk of gestational hypertension in Chinese women

Levels of Polycyclic Aromatic Hydrocarbons in Maternal Serum and Risk of Neural Tube Defects in Offspring

Environmental Factors and Risk for Congenital Heart Disease

A High Concentration of Polycyclic Aromatic Hydrocarbons in Umbilical Cord Tissue is Associated with an Increased Risk for Fetal Neural Tube Defects

Maternal environmental, occupational, and urinary metabolite levels of benzene compounds and their association with congenital heart diseases in offspring: a case‒control study in China

Effects of Prenatal Polycyclic Aromatic Hydrocarbon Exposure on Neonatal Outcomes—MLR and BKMR Models

Levels of PAHs and PAH-DNA Adducts in Placental Tissue and the Risk of Fetal Neural Tube Defects

Maternal Lead Exposure and Risk of Congenital Heart Defects Occurrence in Offspring.

Peri-conceptual and Antenatal Parental Factors and Neonatal Congenital Heart Disease: a Case-Control Study

Prenatal Urinary Polycyclic Aromatic Hydrocarbon Metabolites, Global DNA Methylation in Cord Blood, and Birth Outcomes: A Cohort Study in China.

Polymorphisms in gene UGT1A1 modify the association of prenatal exposure to polycyclic aromatic hydrocarbons with congenital heart diseases risk

Association of polycyclic aromatic hydrocarbons in housewives' hair with hypertension

Risk of maternal exposure to mixed air pollutants during pregnancy for congenital heart diseases in offspring

Biomarkers of Exposure to Combustion By-Products in a Human Population in Shanxi, China

The Association Between Prenatal Exposure to Polycyclic Aromatic Hydrocarbons and Birth Weight: A Meta-Analysis.

Environmental Exposure to Polycyclic Aromatic Hydrocarbons (pahs): the Correlation with and Impact on Reproductive Hormones in Umbilical Cord Serum

Associations Between Urinary Monohydroxylated Polycyclic Aromatic Hydrocarbons and Unexplained Recurrent Spontaneous Abortion and Health Risk Assessment in a Large Case-Control Study in China.